Old Web
English
Sign In
Acemap
>
authorDetail
>
Clayton Smith
Clayton Smith
University of Colorado Denver
Medicine
Internal medicine
Oncology
Venetoclax
Azacitidine
4
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The Intriguing Clinical Success of BCL-2 Inhibition in Acute Myeloid Leukemia
2021
Daniel A. Pollyea
Shanshan Pei
Brett M. Stevens
Clayton Smith
Craig T. Jordan
Show All
Source
Cite
Save
Citations (0)
Allogeneic Transplant Improves AML Outcomes Compared to Maintenance Venetoclax and Azacitidine Following Response to Initial Venetoclax and Azacitidine Therapy
2020
Blood
Daniel A. Pollyea
Amanda Winters
Craig T. Jordan
Clayton Smith
Jonathan A. Gutman
Show All
Source
Cite
Save
Citations (6)
Venetoclax and Azacitidine for Newly Diagnosed Non-Elderly Adult Patients with Acute Myeloid Leukemia and Adverse Risk Features
2020
Blood
Jonathan A. Gutman
Amanda Winters
Maria L. Amaya
Christine M. McMahon
Jeffrey Schowinsky
Diana Abbott
Andrew Hammes
Shanshan Pei
Brett M. Stevens
Craig T. Jordan
Clayton Smith
Daniel A. Pollyea
Show All
Source
Cite
Save
Citations (4)
Venetoclax Is Safe and Tolerable As Post-Transplant Maintenance Therapy for AML Patients at High Risk for Relapse
2020
Blood
Andrew Kent
Daniel A. Pollyea
Amanda Winters
Craig T. Jordan
Clayton Smith
Jonathan A. Gutman
Show All
Source
Cite
Save
Citations (6)
1